Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trialMads Israelsen, Camilla Dalby Hansen, Katrine Holtz Thorhauge et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 74
Sphingolipids Are Depleted in Alcohol-Related Liver FibrosisMaja Thiele, Tommi Suvitaival, Lucas Moitinho‐Silva et al.|Gastroenterology|2023Cited by 53